• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 (+)-海绵抑素 1 类似物的设计、合成与生物评价:经验总结。

Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.

机构信息

Monell Chemical Senses Center and Laboratory for Research on the Structure of Matter, Department of Chemistry, University of Pennsylvania , Philadelphia, 19104, United States.

出版信息

J Am Chem Soc. 2011 Sep 7;133(35):14042-53. doi: 10.1021/ja2046167. Epub 2011 Aug 12.

DOI:10.1021/ja2046167
PMID:21761891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3164888/
Abstract

The design, synthesis, and biological evaluation of two diminutive forms of (+)-spongistatin 1, in conjunction with the development of a potentially general design strategy to simplify highly flexible macrocyclic molecules while maintaining biological activity, have been achieved. Examination of the solution conformations of (+)-spongistatin 1 revealed a common conformational preference along the western perimeter comprising the ABEF rings. Exploiting the hypothesis that the small-molecule recognition/binding domains are likely to comprise the conformationally less mobile portions of a ligand led to the design of analogues, incorporating tethers (blue) in place of the CD and the ABCD components of the (+)-spongistatin 1 macrolide, such that the conformation of the retained (+)-spongistatin 1 skeleton would mimic the assigned solution conformations of the natural product. The observed nanomolar cytotoxicity and microtubule destabilizing activity of the ABEF analogue provide support for both the assigned solution conformation of (+)-spongistatin 1 and the validity of the design strategy.

摘要

已经实现了两种(+)-海绵抑素 1 的小型化形式的设计、合成和生物评价,同时还开发了一种潜在的通用设计策略,可在保持生物活性的同时简化高度灵活的大环分子。(+)-海绵抑素 1 的溶液构象研究揭示了一个共同的构象偏好,沿着西部边界包含 ABEF 环。利用小分子识别/结合结构域可能包含配体中构象移动性较小部分的假设,设计了类似物,用系链(蓝色)代替(+)-海绵抑素 1 大环内酯的 CD 和 ABCD 部分,从而保留的(+)-海绵抑素 1 骨架的构象将模拟天然产物的指定溶液构象。ABE 类似物的纳米级细胞毒性和微管去稳定活性观察结果为(+)-海绵抑素 1 的指定溶液构象和设计策略的有效性提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/b07cb6912083/nihms314301f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/9fe6fea1bb9d/nihms314301f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/95f226dd2172/nihms314301f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/a84219e29249/nihms314301f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/1ed157d75dfd/nihms314301f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/2766ceee45dc/nihms314301f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/819f8c4384d3/nihms314301f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/4c6b23a10f75/nihms314301f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/a1a9e860c23b/nihms314301f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/d9f54f8352f7/nihms314301f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/711316ffc00e/nihms314301f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/d812c5813fa3/nihms314301f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/44a970ef307d/nihms314301f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/b66e92ebd1a5/nihms314301f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/0d384b1137e9/nihms314301f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/ac57ee388092/nihms314301f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/674bb8e94ed4/nihms314301f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/9fed2878e9e8/nihms314301f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/b07cb6912083/nihms314301f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/9fe6fea1bb9d/nihms314301f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/95f226dd2172/nihms314301f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/a84219e29249/nihms314301f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/1ed157d75dfd/nihms314301f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/2766ceee45dc/nihms314301f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/819f8c4384d3/nihms314301f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/4c6b23a10f75/nihms314301f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/a1a9e860c23b/nihms314301f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/d9f54f8352f7/nihms314301f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/711316ffc00e/nihms314301f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/d812c5813fa3/nihms314301f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/44a970ef307d/nihms314301f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/b66e92ebd1a5/nihms314301f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/0d384b1137e9/nihms314301f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/ac57ee388092/nihms314301f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/674bb8e94ed4/nihms314301f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/9fed2878e9e8/nihms314301f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8936/3164888/b07cb6912083/nihms314301f18.jpg

相似文献

1
Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.微小 (+)-海绵抑素 1 类似物的设计、合成与生物评价:经验总结。
J Am Chem Soc. 2011 Sep 7;133(35):14042-53. doi: 10.1021/ja2046167. Epub 2011 Aug 12.
2
Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1.(+)-海绵抑素 1 的 EF-和 ABEF-类似物的设计、合成与生物评价。
Org Lett. 2010 Apr 16;12(8):1792-5. doi: 10.1021/ol100418n.
3
In vitro and in vivo anticancer activity of (+)-spongistatin 1.(+)-海绵抑素 1 的体外及体内抗癌活性。
Anticancer Res. 2011 Sep;31(9):2773-9.
4
The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis.海洋化合物海绵抑素 1 靶向胰腺肿瘤的进展和转移。
Int J Cancer. 2010 Sep 1;127(5):1096-105. doi: 10.1002/ijc.25241.
5
Development of a novel inducer of protein-protein interactions based on aplyronine A.基于阿朴若林 A 开发新型蛋白-蛋白相互作用诱导剂。
Chem Commun (Camb). 2018 Aug 21;54(68):9537-9540. doi: 10.1039/c8cc04613a.
6
Selected hybrid natural products as tubulin modulators.选定作为微管蛋白调节剂的杂合天然产物。
Eur J Med Chem. 2015 Apr 13;94:497-508. doi: 10.1016/j.ejmech.2014.10.062. Epub 2014 Oct 29.
7
Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1.高度有效的海绵抑素 1 的 D 环修饰和连接子装备的类似物的设计和 22 步合成。
Nat Commun. 2018 Nov 9;9(1):4710. doi: 10.1038/s41467-018-07259-x.
8
Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.全合成设计的微管稳定剂抗癌药物紫杉醇、discodermolide 和 dictyostatin 杂交文库。
Chem Commun (Camb). 2010 Jan 14;46(2):261-3. doi: 10.1039/b921237j. Epub 2009 Nov 24.
9
Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents.作为微管蛋白聚合的秋水仙碱位点抑制剂和血管破坏剂的OXi8006的2-苯基吲哚类似物的设计、合成及生物学评价
Bioorg Med Chem. 2025 Feb 1;118:117981. doi: 10.1016/j.bmc.2024.117981. Epub 2024 Nov 7.
10
Design, synthesis and biological studies of novel tubulin inhibitors.新型微管蛋白抑制剂的设计、合成及生物学研究。
Bioorg Med Chem Lett. 2013 Aug 1;23(15):4465-8. doi: 10.1016/j.bmcl.2013.04.078. Epub 2013 May 7.

引用本文的文献

1
Linear (-)-Zampanolide: Flexibility in Conformation-Activity Relationships.线性 (-)-扎潘内酯:构效关系中的灵活性。
ChemMedChem. 2023 Oct 4;18(19):e202300292. doi: 10.1002/cmdc.202300292. Epub 2023 Aug 10.
2
BICePs v2.0: Software for Ensemble Reweighting Using Bayesian Inference of Conformational Populations.BICePs v2.0:使用基于贝叶斯推断的构象族的集合重加权软件。
J Chem Inf Model. 2023 Apr 24;63(8):2370-2381. doi: 10.1021/acs.jcim.2c01296. Epub 2023 Apr 7.
3
Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1.高度有效的海绵抑素 1 的 D 环修饰和连接子装备的类似物的设计和 22 步合成。
Nat Commun. 2018 Nov 9;9(1):4710. doi: 10.1038/s41467-018-07259-x.
4
Model Selection Using BICePs: A Bayesian Approach for Force Field Validation and Parameterization.使用 BICePs 进行模型选择:一种用于力场验证和参数化的贝叶斯方法。
J Phys Chem B. 2018 May 31;122(21):5610-5622. doi: 10.1021/acs.jpcb.7b11871. Epub 2018 Mar 23.
5
Evolution of an Efficient and Scalable Nine-Step (Longest Linear Sequence) Synthesis of Zincophorin Methyl Ester.高效且可扩展的九步(最长线性序列)合成锌卟啉甲酯的方法的演变。
J Am Chem Soc. 2017 Mar 29;139(12):4568-4573. doi: 10.1021/jacs.7b01590. Epub 2017 Mar 15.
6
Conformation-activity relationships of polyketide natural products.聚酮类天然产物的构象-活性关系
Nat Prod Rep. 2015 Aug;32(8):1183-206. doi: 10.1039/c5np00014a.
7
Toward a more step-economical and scalable synthesis of spongistatin 1 to facilitate cancer drug development efforts.朝着更具步骤经济性和可扩展性的海绵他汀1合成方向发展,以促进癌症药物开发工作。
Chem Sci. 2013 Apr 1;4(4):1497-1501. doi: 10.1039/C3SC22186E.
8
Hydroxyl-directed stereoselective diboration of alkenes.烯烃的羟基导向立体选择性双硼化反应
J Am Chem Soc. 2014 Jul 2;136(26):9264-7. doi: 10.1021/ja504228p. Epub 2014 Jun 24.
9
Conformational preferences of zampanolide and dactylolide.扎那米韦和达托霉素的构象偏好。
Org Lett. 2013 Oct 18;15(20):5246-9. doi: 10.1021/ol402462h. Epub 2013 Oct 8.
10
In vitro and in vivo anticancer activity of (+)-spongistatin 1.(+)-海绵抑素 1 的体外及体内抗癌活性。
Anticancer Res. 2011 Sep;31(9):2773-9.

本文引用的文献

1
The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment.海绵他汀类化合物:结构复杂的天然产物——第一部分:通过构建高级ABCD片段对(+)-海绵他汀1进行形式合成。
Angew Chem Int Ed Engl. 2001 Jan 5;40(1):191-195. doi: 10.1002/1521-3773(20010105)40:1<191::AID-ANIE191>3.0.CO;2-C.
2
Diversity-oriented synthesis leads to an effective class of bifunctional linchpins uniting anion relay chemistry (ARC) with benzyne reactivity.导向多样性合成得到了一类有效的双功能链接子,它将阴离子接力化学(ARC)与苯炔反应性结合在一起。
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6787-92. doi: 10.1073/pnas.1015265108. Epub 2011 Jan 18.
3
Spirastrellolide Studies. Synthesis of the C(1)-C(25) Southern Hemispheres of Spirastrellolides A and B, Exploiting Anion Relay Chemistry.螺旋星孢菌素研究。利用阴离子接力化学合成螺旋星孢菌素A和B的C(1)-C(25)南半球部分。
Tetrahedron. 2010 Aug 14;66(33):6597-6605. doi: 10.1016/j.tet.2010.01.082.
4
Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.海绵吡喃的合成研究。(+)-海绵他汀1的可扩展全合成的演变
Tetrahedron. 2009 Sep 15;65(33):6489-6509. doi: 10.1016/j.tet.2009.04.003.
5
Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1.(+)-海绵抑素 1 的 EF-和 ABEF-类似物的设计、合成与生物评价。
Org Lett. 2010 Apr 16;12(8):1792-5. doi: 10.1021/ol100418n.
6
Benzyl and phenylthiomethyl silanes: a new class of bifunctional linchpins for type II anion relay chemistry (ARC).苄基和苯硫甲基硅烷:II 型阴离子中继化学 (ARC) 的新一类双功能连接子。
Org Lett. 2010 Mar 19;12(6):1260-3. doi: 10.1021/ol100130x.
7
Spongipyran Synthetic Studies. Total Synthesis of (+)-Spongistatin 2.海绵吡喃的合成研究。(+)-海绵他汀2的全合成。
Tetrahedron. 2009 Aug 15;65(33):6470-6488. doi: 10.1016/j.tet.2009.04.001.
8
Uniting anion relay chemistry with Pd-mediated cross coupling: design, synthesis and evaluation of bifunctional aryl and vinyl silane linchpins.将阴离子接力化学与 Pd 介导的交叉偶联相结合:双功能芳基和乙烯基硅烷连接子的设计、合成和评价。
Org Lett. 2010 Feb 5;12(3):588-91. doi: 10.1021/ol902784q.
9
(+)-Rimocidin synthetic studies: construction of the C(1-27) aglycone skeleton.(+)-Rimocidin 合成研究:C(1-27)糖苷配基骨架的构建。
J Org Chem. 2009 Aug 21;74(16):5987-6001. doi: 10.1021/jo900765p.
10
Evolution of multi-component anion relay chemistry (ARC): construction of architecturally complex natural and unnatural products.多组分阴离子中继化学(ARC)的发展:构建结构复杂的天然和非天然产物。
Chem Commun (Camb). 2008 Dec 7(45):5883-95. doi: 10.1039/b810394a. Epub 2008 Sep 30.